Integrative analysis of GWAS and transcriptomics data reveal key genes for non-small lung cancer

被引:1
|
作者
Feng, Xiangxiong [1 ]
机构
[1] Univ Calif Davis, Shields Ave, Davis, CA 95616 USA
关键词
GWAS; Transcriptomics; Lung cancer; Machine learning; SUSCEPTIBILITY LOCI; RISK-FACTORS; ASSOCIATION; HETEROGENEITY; STATISTICS; SMOKING; DISEASE;
D O I
10.1007/s12032-023-02139-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is one of the world's most common and deadly cancers. The two main types of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). More than 85% of lung cancers are NSCLC. Genetic factors play a significant role in the risk of NSCLC. Growing studies focus on studying risk factors at the molecular level. The aim of the study is to build a pipeline to integrate Genome-wide association analysis (GWAS) and transcriptomics data with machine learning to effectively identify genetic risk factors of NSCLC. GWAS datasets and GWAS summary data were downloaded from GWAS catalog, which include lung carcinoma genetic variants among the European population. Then, with the GWAS summary, data functional analysis of significant SNPs was performed using a webserver called FUMAGWAS. The transcriptomics data of NSCLC and non-NSCLC people were used to build a machine learning model to identify the key genes that help predict the NSCLC. The top up-regulation and down-regulation genes were identified by the BART cancer webserver, and the mechanistic roles of the genes were validated by literature review. By performing integrative analysis of GWAS and transcriptomics analysis using machine learning, we identified multiple SNPs and genes that related to NSCLC. The computational pipeline may facilitate the biomarker discovery for NSCLC and other diseases.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
    Nicos, Marcin
    Krawczyk, Pawel
    Jarosz, Bozena
    Sawicki, Marek
    Szumillo, Justyna
    Trojanowski, Tomasz
    Milanowski, Janusz
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (02) : 169 - 176
  • [42] Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer
    Campa, Daniele
    Zienolddiny, Shanbeh
    Lind, Helge
    Ryberg, David
    Skaug, Vidar
    Canzian, Federico
    Haugen, Aage
    LUNG CANCER, 2007, 56 (01) : 17 - 23
  • [43] Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study
    Xu, Yinghui
    Wang, Yanru
    Liu, Hongliang
    Kang, Xiaozheng
    Li, Wei
    Wei, Qingyi
    ONCOTARGET, 2016, 7 (38) : 61716 - 61727
  • [44] Analysis of ferritinophagy-related genes associated with the prognosis and regulatory mechanisms in non-small cell lung cancer
    Hao, Yuan
    Wang, Xin
    Ni, Zerong
    Ma, Yuhui
    Wang, Jing
    Su, Wen
    FRONTIERS IN MEDICINE, 2025, 12
  • [45] Concordant expression of the telomerase-associated genes in non-small cell lung cancer
    Hsu, CP
    Miaw, J
    Hsia, JY
    Shai, SE
    Chen, CY
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (07): : 594 - 599
  • [46] Radiotherapy of non-small cell lung cancer
    Kleine, P.
    Flentje, M.
    PNEUMOLOGE, 2016, 13 (04): : 241 - +
  • [47] Paclitaxel for non-small cell lung cancer
    Ramalingam, S
    Belani, CP
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1771 - 1780
  • [48] Pneumonectomy for non-small cell lung cancer
    Yoshinobu Ichiki
    Akira Nagashima
    Yasuhiro Chikaishi
    Manabu Yasuda
    Surgery Today, 2012, 42 : 830 - 834
  • [49] Staging of non-small cell lung cancer
    Tanoue, Lynn T.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 29 (03) : 248 - 260
  • [50] Pneumonectomy for Non-Small Cell Lung Cancer
    Sugarbaker, David J.
    Haywood-Watson, Ricky J.
    Wald, Ori
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 533 - +